WeVote
Log In

Bill

Bill

SB 2283

RELATING TO PRESCRIPTION DRUGS.

2026 Regular Session Introduced by Stanley Chang and 4 co-sponsors

Hawaii bill SB 2283 addresses prescription drug policy; currently in committee with public hearing scheduled for February 2026.

The committee(s) on HHS has scheduled a public hearing on 02-09-26 1:05PM; Conference Room 225 & Videoconference.
#communityretailpharmacies #mailorderpharmacies #prohibitions
0
WeVote Research Nonpartisan
Bill Summary · SB 2283

Legislative bill overview

SB 2283 is a Hawaii bill relating to prescription drugs that was introduced in January 2026 and is currently in committee review. The bill has passed first reading and is scheduled for a public hearing before the Health and Human Services Committee on February 9, 2026. The specific provisions of the bill are not detailed in the available information.

Why is this important

Prescription drug policy directly affects healthcare costs and accessibility for Hawaii residents. Legislation in this area typically addresses pricing, insurance coverage, drug availability, or pharmacy regulations—issues with significant impact on both individual healthcare expenses and the state's healthcare system.

Potential points of contention

  • Specific provisions unknown — Without access to the bill's actual text, the nature of potential controversy cannot be determined; it could involve price controls, insurance requirements, or other mechanisms
  • Healthcare cost vs. industry concerns — Likely tension between consumer/patient advocates seeking lower costs and pharmaceutical/pharmacy industry representatives concerned about profit margins
  • Federal vs. state authority — Questions may arise about whether Hawaii's measures conflict with federal drug regulation or interstate commerce

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.